Accelerating the journey from discovery to impact
Extraordinary science
Scientific breakthroughs begin with curiosity. Turning them into meaningful advances in human health demands speed, insight and the right technology.
At SCIEX, part of Danaher’s global ecosystem of life sciences innovators, we help researchers move from discovery to impact faster. By combining advanced mass spectrometry technologies with deep scientific expertise, we empower scientists to generate actionable insights with greater confidence, enabling them to tackle some of the most complex questions in biomedical and omics research.
Extraordinary science. Real-world impact.
The concept of “extraordinary science” captures moments when research challenges existing understanding and opens new possibilities for discovery.
Through this collection, leading researchers share how they are advancing knowledge across proteomics, metabolomics, lipidomics and translational research using the ZenoTOF 7600 system. Their work demonstrates how innovation, collaboration and scientific rigor can accelerate progress toward improved health outcomes.
Whether uncovering new disease mechanisms, advancing personalized medicine or accelerating drug development, these scientists are transforming complex data into meaningful discoveries that bring us closer to a healthier future.
Learn from scientists advancing the frontiers of discovery
Progress in life sciences happens when expertise, technology and collaboration come together.
Explore presentations from global leaders who are leveraging next-generation mass spectrometry workflows to:
- Accelerate biomarker discovery and translational research
- Advance precision and personalized medicine
- Improve understanding of aging-related diseases
- Enable high-throughput drug development workflows
- Unlock deeper biological insights through proteomics, metabolomics and lipidomics
- Expand access to powerful omics capabilities across research communities
These researchers demonstrate what becomes possible when cutting-edge instrumentation is paired with scientific excellence and a commitment to solving the hardest problems together.
Powered by connected science
Today's most important scientific challenges cannot be solved in isolation.
As part of Danaher, SCIEX connects researchers to a broader ecosystem of technologies, expertise and innovation that spans discovery through application. This connected approach helps scientists streamline workflows, generate deeper insights and accelerate progress across the entire research journey.
From single-cell proteomics and immunopeptidomics to metabolomics and lipidomics, SCIEX solutions help turn scientific potential into measurable impact.
Explore the series
Watch leading scientists share the breakthroughs, methodologies and technologies shaping the future of biomedical and omics research.
Faster, deeper, simpler: a new era in metabolomics and lipidomics profiling
Nicola Zamboni, Adjunct Professor at ETH Zurich, Institute of Molecular Systems Biology - Streamlining metabolomic and lipidomic analyses to enable personalized therapies
Watch now
Unlocking the secrets of aging-related diseases
Professor Birgit Schilling, PhD Director of the Mass Spectrometry Core Schilling Laboratory, The Buck Institute for Research on Aging - Data-independent acquisition (DIA) on a ZenoTOF 7600 system deciphered mechanisms during acute kidney injury (AKI) and differentiated 5 human breast cancer subtypes analyzing FFPE specimen
Watch now
Revolutionizing the immune system study with immunopeptidomics
Professor Anthony Purcell, PhD Monash University, Biochemistry and Molecular Biology Purcell Laboratory, Monash Biomedicine - Discovery Institute Zeno SWATH DIA and the hunt for cancer antigens
Watch now
Exploring high-throughput proteomics for new drug development
Hugo Gagnon Chief Scientific Officer, Allumiqs - High-throughput proteomics in drug development with Zeno SWATH DIA for PROTAC screening and CRISPR validation applications
Watch now
Investigating the impactful role of proteomics in sepsis management
Iulia Macavei Jérôme Lemoine's Laboratory Institute of Analytical Sciences, France - Fast and accurate identification and antibiotic resistance profiling of microorganisms in blood cultures by SWATH DIA proteomics
Watch now
Advancing personalized medicine with single cell proteomics (SCP)
Benjamin C. Orsburn, PhD Instructor of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine - Democratizing single cell proteomics with microflow time-of-flight mass spectrometry
Watch now
Enhancing epigenetic modification analysis using LC-MS/MS
Ben Garcia, head of Biochemistry and Molecular Biophysics, Washington University in St. Louis - Initial impressions of the ZenoTOF 7600 system for comprehensive analysis of post-translational and post-transcriptional modifications
Watch now
Proteomic profiling of drug metabolizing enzymes in the brain using LC-MS/MS
Abigail Wheeler, senior scientist at Merck - Identification of low-abundance drug metabolizing enzymes in the brain using targeted mass spectrometry-based proteomics
Watch now
Omics related content
Lipidomics
Simplify lipidomics approaches and accelerate your research. Discover, identify and quantify thousands of lipids with confidence. Overcome the challenges of diverse lipid classes and molecular compounds with enhanced selectivity and powerful, time-saving solutions.
Learn more
Proteomics
Explore the depth and complexity of the proteome. Accelerate your understanding of biology with streamlined data acquisition, processing and interpretation solutions that can be applied to a single sample or on an industrial scale across large cohorts.
Learn more
Food omics
Learn about large-scale omics profiling from field to fork and beyond. Explore a comprehensive approach to food and nutrition analysis.
Learn more
Metabolomics
Discover comprehensive solutions that facilitate both targeted and untargeted metabolomics, enabling researchers to uncover detailed metabolic profiles and gain insights into biological systems, ultimately driving discoveries in drug development, biomarker identification, and disease understanding.
Learn more
Let's connect
Stay up-to-date with omics conversations on LinkedIn and X